Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from William Blair

The Bloodshed in Palantir Stock Is So Bad This Analyst Just Upgraded the Stock

A continued rout in Palantir stock made one of its long-time skeptics change his stance on the big data analytics firm on Wednesday.

NeoGenomics Is On The Upswing, Reversing A CEO-Tied Sell-Off, On Bullish Long-Term Guidance

NeoGenomics Is On The Upswing, Reversing A CEO-Tied Sell-Off, On Bullish Long-Term Guidance

NeoGenomics stock jumped Wednesday after the company issued a strong 2025 outlook. That partially reversed a recent selloff.

Investors Business Daily

Affirm, SoFi Initiated At Outperform In Consumer Digital Financing

Affirm, SoFi Initiated At Outperform In Consumer Digital Financing

William Blair initiated coverage of Affirm stock and SoFi with outperform ratings viewing them as share gainers in the consumer financing market.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Meta's Generative AI Push Could Bring Big 'Windfall' For WhatsApp, Analyst Says

A Meta stock analyst said the company's generative AI push could help drive new revenue from WhatsApp through chatbots.

Investors Business Daily

3 Tech Stocks to Buy for Steady Growth in 2025

These companies all have huge growth potential in 2025 thanks to innovation and transformation in industries like data centers and artificial intelligence.

These Drone Stocks May Be On The Case In New Jersey

Drone stocks have gotten a tailwind from mysterious sightings over New Jersey. Axon and AeroVironment are among those who stand to benefit, William Blair said.

Investors Business Daily

Regulatory Setback For Applied Therapeutics' Lead Program, FDA Highlights Deficiencies In Clinical Application

FDA rejected Applied Therapeutics' Govorestat for galactosemia, citing NDA deficiencies. The company plans discussions for resubmission or appeal.

inkl

Read news from The Economist, FT, and more,
with one subscription

Chipotle's new CEO gets approving nod from analysts

Chipotle's new CEO gets approving nod from analysts

Boatwright is likely to look to new CFO Adam Rymer as a strategic partner.

Insulet Soars Out Of Buy Zone As 'Beat-And-Raise Cadence' Continues

Insulet Soars Out Of Buy Zone As 'Beat-And-Raise Cadence' Continues

Insulet stock soared out of a buy zone Friday after the insulin pump-maker "continued the beat-and-raise cadence it has seen in 2024."

Investors Business Daily

Viking Therapeutics Stock Swings Wildly After Weight-Loss Drug Data

Viking Therapeutics Stock Swings Wildly After Weight-Loss Drug Data

Viking Therapeutics stock is volatile Monday after the pharma company released positive data for its weight-loss drug. Here's what you need to know.

Royal Caribbean Clears Entry, Surges On Results, Hiked Guidance

Royal Caribbean Clears Entry, Surges On Results, Hiked Guidance

Royal Caribbean stock surged to clear an add-on opportunity Tuesday after the cruise giant hiked its outlook with Q3 results.

Investors Business Daily

1 AI Growth Stock to Grab While It's Under $100

1 AI Growth Stock to Grab While It's Under $100

This AI stock is currently trading below $100 following a pullback, which could be a perfect window for investors to snag this growth stock now.

Stock Of The Day: SPX Technologies Rides Data Centers, Pharma-Led Growth To Big Gains

Stock Of The Day: SPX Technologies Rides Data Centers, Pharma-Led Growth To Big Gains

SPX Technologies is Stock Of The Day as the HVAC innovator capitalizes on growth opportunities serving data centers, drugmakers and more.

Investors Business Daily

Top Stocks For Q4: 6 Consumer, Housing And Infrastructure Stocks

Top Stocks For Q4: 6 Consumer, Housing And Infrastructure Stocks

Keep your eye on these six top stocks for Q4 in the consumer, infrastructure and housing sectors, including Steven Madden and Wolverine World Wide.

Investors Business Daily

Get all your
news in one place.

100’s of premium titles.
One news app.

Moderna Stock Plunges as Vaccine Maker Slashes R&D Budget: What to Know

Moderna stock is plunging Thursday after the COVID-19 vaccine maker announced plans to drastically cut its R&D spending to focus on new product approvals.

Is Tesla Stock a Buy for Energy Storage Upside?

This article explores whether Tesla stock is a good investment for those looking to capitalize on the potential growth of its energy storage business, which is increasingly seen as a significant driver of future upside.

Chewy Stock Soars on Big Profit Beat. Is It Time to Buy?

Chewy is red-hot Wednesday after the pet products retailer posted impressive Q2 earnings. Here's what Wall Street has to say about the stock.

Investors Business Daily

As Diabetes Battle Heats Up, Spotlight Turns To Dexcom, Abbott

The diabetes donnybrook between Abbott Laboratories and Dexcom is poised to heat up — and could bolster both Abbott stock and Dexcom stock.

Get all your
news in one place.

100’s of premium titles.
One news app.

Visa Is the Worst Dow Stock Wednesday. Here's Why

Visa stock is down sharply Wednesday after the credit card company came up short of revenue expectations for its fiscal Q3.

Investors Business Daily

CrowdStrike Outage Updates: These Disruptions Persist

Business operations across various industries were disrupted worldwide Friday due to a CrowdStrike outage. Stocks fall.

Investors Business Daily

Meta, JPMorgan Lead Five Stocks Near Buy Points

Meta Platforms and JPMorgan Chase lead this weekend's watch list of five stocks near buy points as the S&P 500 enters the second half of 2024 in stride.

Investors Business Daily

IBD 50 Data Storage Stock Has Big AI Opportunity, Analysts Say

Pure Storage stock traded lower Friday despite positive takeaways from analysts following a presentation Thursday.

Dave & Buster's Stock Tanks on Earnings Miss: What To Know

Dave & Buster's stock is plunging after the entertainment and restaurant chain reported weaker-than-expected Q1 earnings. Here's what you need to know.

Investors Business Daily

How Mandiant Deal Turbocharged Google's Cybersecurity Push

Will Alphabet's 2022 acquisition of cybersecurity firm Mandiant turn out to be a home run for Google stock, like YouTube, or less of a game-changer?

Investors Business Daily

IBD Stock Of The Day Medpace Flirts With Breakout After Big Earnings Reversal

Medpace is Wednesday's IBD Stock Of The Day. Medpace stock reversed Tuesday after a mixed first-quarter report.

People

100,724 stories

Scott Boatwright

Stéphane Bancel

Margaret Kaczor Andrew

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

US Federal Reserve

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

253,633 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play